Navigation Links
ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor
Date:5/11/2011

href="http://www.viropharma.com/Products.aspx">http://www.viropharma.com/Products.aspx.

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's website, http://www.viropharma.com/. The company encourages investors to consult these sections for more information on ViroPharma and our business

Forward Looking Statements

Certain statements in this press release contain forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements provide our current expectations or forecasts of future events, including the therapeutic indication and use, safety, efficacy, tolerability and potential of Cinryze and our focus, goals, strategy, research and development programs, and ability to develop pharmaceutical products, commercialize pharmaceutical products, and execute on our plans including clinical development activities with Cinryze related to subcutaneous administration. There can be no assurance that that our clinical program with Cinryze utilizing subcutaneous administration in combination with rHuPH20 will yield positive results or support further development of Cinryze for subcutaneous administration in combination with rHuPH20. The FDA or EMA may view the data regarding subcutaneous administration of Cinryze in combination with rHuPH20 as insufficient or inconclusive, request additional data, require additional clinical studies, delay any decision past the time frames anticipated by us, limit any approved indications, or deny the approval of Cinryze for subcutaneous administration in combination with rHuPH20. These factors, and other factors, including, but not limited to those described in our annual report on Form 10-K for the year ended December 31, 2010 and quarterly reports on Form 10-Q filed with the Securities and Exchange Commission, could cause fu
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. ViroPharma to Present at the Natixis Bleichroeder Conference
3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 31, 2015 The Indiana Medical Device Manufacturers ... The MedTech/Life Sciences Policy Forum to state legislators. The ... at Roche Diagnostics in Indianapolis ... Sue Ellspermann and State Sen. Brandt ... of Roche,s new Learning & Development Center, which is ...
(Date:8/31/2015)... PHOENIX , Aug. 31, 2015  DICOM ... announced today that it was recognized as a ... Radiology software.  The awards are sponsored ... and related professionals in the medical imaging industry.  ... for radiology professionals to acknowledge the contributions of ...
(Date:8/31/2015)... 31, 2015 Pepperl+Fuchs, a world leader ... Corporation, a leading provider of HART protocol devices. ... further extend its integrated solutions offerings and strengthen ... "We are pleased to add the MACTek ... Jim Bolin , Pepperl+Fuchs, executive vice president ...
Breaking Medicine Technology:Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 2Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 3DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2
... July 12 Ferring Pharmaceuticals Inc., the makers of ... Bat for the Cure charity, in an effort to "strike-out ... the organization,s Minor League Baseball initiative across the country. FIRMAGON® is ... , , ...
... (B. Braun) announced today the availability of large volume heparin infusion solutions. , ... (Logo:   http://photos.prnewswire.com/prnh/20081022/NYW008LOGO ) , ...   http://www.newscom.com/cgi-bin/prnh/20081022/NYW008LOGO ) , , , ... States Pharmacopeia (USP) standards for heparin products released by the U.S. Food and Drug Administration ...
Cached Medicine Technology:Ferring Pharmaceuticals' FIRMAGON® Named Official Sponsor of Ed Randall's Bat for the Cure 2Ferring Pharmaceuticals' FIRMAGON® Named Official Sponsor of Ed Randall's Bat for the Cure 3Ferring Pharmaceuticals' FIRMAGON® Named Official Sponsor of Ed Randall's Bat for the Cure 4B. Braun Large Volume Heparin Infusion Solutions Now Available 2B. Braun Large Volume Heparin Infusion Solutions Now Available 3
(Date:8/31/2015)... ... 31, 2015 , ... The Bay Pines VA Healthcare System (VAHCS) ... by hiring more doctors and nurses and expanding existing facilities and services. Spine ... July, Dr. Anthony Jabre was selected to lead and grow the Bay Pines VAHCS’s ...
(Date:8/31/2015)... ... 31, 2015 , ... The Sundance Film Festival award winning documentary “Alive Inside” ... Inside” shadows a social worker who advocates for the use of music therapy for ... music to residents in health care centers who may have lost a spark in ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... In an ... from the Plastic and Reconstructive Surgery Global Open Journal that discusses the future of ... article discussed how, in the future, customized implants, prosthetics, and other 3-D printed tools ...
(Date:8/31/2015)... ... September 01, 2015 , ... ... traumatic brain injury with emphasis on transcranial near-infrared laser phototherapy ”. , As ... brain injury has been largely untreatable - with mostly palliative treatments only - ...
(Date:8/31/2015)... ... August 31, 2015 , ... Garden State Urology ... the result of a merger of five of the busiest urology practices in ... provide more cost-effective and higher quality care than they did individually. Their ...
Breaking Medicine News(10 mins):Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 2Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 3Health News:Public Invited to Dementia Documentary Screening at North Carolina Retirement Community 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 3Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 2Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 3Health News:NJ Top Docs Presents, Garden State Urology! 2
... reduce infant mortality in the U.S., according to a study ... A 10 percent increase in hospital use of basic ... births, the study found. A complete national transition to electronic ... the U.S. Many health professionals have advocated electronic records ...
... May 18, 2011 The American Society for Gastrointestinal ... of its program specifically dedicated to promoting quality in ... the United States. The ASGE Endoscopy Unit Recognition Program ... privileging, quality assurance, endoscopy reprocessing and CDC infection control ...
... 18 (HealthDay News) -- A flame retardant banned years ago in ... is among a number of potentially toxic flame retardants found in ... chairs, a new study reports. Flame retardants are used to ... number of products -- catching fire, and to slow the rate ...
... , WEDNESDAY, May 18 (HealthDay News) -- Deprivation and ... new study suggests. Researchers examined DNA samples collected ... Romania taking part in a long-term study. Some of ... transferred to high-quality foster care at different ages. ...
... you run a mile? If you,re middle-aged, the answer could ... stroke over the next decade or more. In two separate ... a middle-age person can run a mile can help predict the ... men and could be an early indicator of cardiovascular disease for ...
... care in the United States says that the rapidly growing ... ill patients raises serious concerns about whose interests are being ... those of dying patients and their loved ones. "Under ... of interest between a company,s drive to maximize profits and ...
Cached Medicine News:Health News:Electronic medical records lower infant mortality, study finds 2Health News:ASGE recognizes 30 endoscopy units for quality and safety 2Health News:ASGE recognizes 30 endoscopy units for quality and safety 3Health News:Potentially Toxic Flame Retardants Found in Baby Products 2Health News:Early Adversity May Shorten Child's Life 2Health News:Simple fitness test could predict long-term risk for heart attack, stroke in middle-aged people 2Health News:Simple fitness test could predict long-term risk for heart attack, stroke in middle-aged people 3Health News:Rise of for-profit hospice industry raises troubling questions, new study says 2
Investigational use spacer with Cantilever Transforminal Lumbar Interbody Fusion and instrumentation. For Investigational use only. 7 mm height....
... System is the most widely ... Reliability, flexibility, versatility and ease-of-use ... the Leksell Stereotactic System. The ... center-of-arc principle and the basic ...
VG2 PLIF (Parallel) Posterior lumbar interbody fusion. Frozen preservation. Consists of two outer cortical planks, center cancellous plank, all from the same donor, held together by two press-fit cor...
Allograft implants can be easily used to repair and promote the healing of a wide variety of bone and other tissue defects....
Medicine Products: